Frazier Life Sciences Acquisition Corp. II Form S-1 — Sep 23, 2026
Frazier Life Sciences Acquisition Corp. II filed an S-1 for a $75 million IPO of 7,500,000 Class A ordinary shares priced at $10.00, with Jefferies as sole book-running manager and a planned Nasdaq listing under symbol FLSC. Unlike many SPAC IPOs, investors receive no warrants. The Frazier Life Sciences Public Fund will commit to a minimum $25 million forward purchase at $10.00 per share at the time of a business combination, and the sponsor is purchasing $3 million of private placement shares.
Key figures
- Gross Proceeds
- 75000000
- Offering Price
- 10
- Shares Offered
- 7500000
- Founder Shares
- 1875000
- Trustee Amount
- 75000000
- Completion Window Months
- 24
- Private Placement Shares
- 300000
- Private Placement Proceeds
- 3000000
- Forward Purchase Commitment
- 25000000
- Underwriting Discount Per Share
- 0.6
- Deferred Underwriting Commissions
- 3000000
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.